These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions. Winnicki M; Shear NH Am J Clin Dermatol; 2011 Jun; 12(3):171-80. PubMed ID: 21469762 [TBL] [Abstract][Full Text] [Related]
9. Three cases of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by proton-pump inhibitors. Spigariolo CB; Barei F; Maronese CA; Barberi F; Cattaneo A; Violetti SA Australas J Dermatol; 2022 Nov; 63(4):509-512. PubMed ID: 35877187 [TBL] [Abstract][Full Text] [Related]
10. First case of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) due to Berberine, an over-the-counter herbal glycemic control agent. Labadie JG; Florek AG; Croitoru A; Liu W; Krunic AL Int J Dermatol; 2018 Sep; 57(9):e68-e70. PubMed ID: 29808929 [No Abstract] [Full Text] [Related]
12. Symmetrical drug-related intertriginous and flexural exanthema secondary to topical 5-fluorouracil. Powers R; Gordon R; Roberts K; Kovach R Cutis; 2012 May; 89(5):225-8. PubMed ID: 22768435 [TBL] [Abstract][Full Text] [Related]
13. Symmetrical drug-related intertriginous and flexural exanthema due to codeine. Erfan G; Yanik ME; Kaya S; Tasolar K; Oznur M; Kulac M Indian J Dermatol Venereol Leprol; 2015; 81(4):405-6. PubMed ID: 26087105 [No Abstract] [Full Text] [Related]
14. Symmetric drug-related intertriginous and flexural exanthema: Clinicopathologic study of 19 cases and review of literature. Schuler AM; Smith EH; Chaudet KM; Bresler SC; Gudjonsson JE; Kroshinsky D; Nazarian RM; Chan MP J Cutan Pathol; 2021 Dec; 48(12):1471-1479. PubMed ID: 34159622 [TBL] [Abstract][Full Text] [Related]
15. Clozapine-induced symmetrical drug-related intertriginous and flexural exanthema: first reported cases. Rao A; Francis N; Morar N Br J Dermatol; 2012 May; 166(5):1142-3. PubMed ID: 22121994 [No Abstract] [Full Text] [Related]
16. Symmetrical drug-related intertriginous and flexural exanthema/baboon syndrome induced by traditional Chinese medicine. Liu J; Li LF J Cosmet Dermatol; 2022 May; 21(5):2200-2204. PubMed ID: 34333850 [TBL] [Abstract][Full Text] [Related]
17. Paracetamol-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient receiving apremilast therapy. Megna M; Cinelli E; Napolitano M; Fabbrocini G; Patruno C Contact Dermatitis; 2019 Dec; 81(6):451-454. PubMed ID: 31328275 [No Abstract] [Full Text] [Related]
18. First case of symmetric drug-related intertriginous and flexural exanthema (sdrife) due to rivastigmine? Allain-Veyrac G; Lebreton A; Collonnier C; Jolliet P Am J Clin Dermatol; 2011 Jun; 12(3):210-3. PubMed ID: 21469764 [TBL] [Abstract][Full Text] [Related]
19. Sebotropic eruption associated with use of oral kava kava supplement. Huynh JC; Asgari MM; Moore MM Clin Exp Dermatol; 2014 Oct; 39(7):816-8. PubMed ID: 25214405 [TBL] [Abstract][Full Text] [Related]
20. Symmetrical drug-related intertriginous and flexural exanthema due to ranitidine. Binitha MP; Sasidharanpillai S; John R; Sherjeena PV Indian J Pharmacol; 2014; 46(5):551-2. PubMed ID: 25298589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]